Retail-level recall of one batch of Twynsta (telmisartan / amlodipine) 40mg/10mg Tablets due to erroneous distribution of rejected batch.
| Date of recall: | 22 September 2023 |
| Product: | Twynsta Tablets |
| Active Ingredient: | Telmisartan 40mg, Amlodipine 10mg |
| Product Category: | Therapeutic product |
| Batch No.: | 22E2317 |
| Class of Recall: | 2 |
| Level of Recall: | Retail |
| Local Company: | Boehringer Ingelheim Singapore Pte Ltd |
| Description of Issue: | Erroneous distribution of rejected batch due to missing of transport temperature data logger |
| Recall Instructions: | Hospitals, clinics, pharmacies: Stop supplying the affected batch and return the remaining stocks to the company. |
The Health Sciences Authority (HSA) releases information regarding the withdrawal of health products available in Singapore. These withdrawals can happen either voluntarily by companies or in response to a request from HSA due to concerns about the products’ quality, safety, or effectiveness.
Initiating a withdrawal doesn’t necessarily indicate that a product is unsafe or ineffective. It can also occur to eliminate items with quality issues that don’t affect safety or effectiveness. The purpose is to uphold the high regulatory standards set by HSA for products sold in Singapore.
Not all withdrawals result in official announcements. However, if a withdrawal involves a widely distributed product or one that poses a significant health risk, HSA will issue a press release to inform the general public.
Class of recall
A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.
- Class 1: For recalls of products with issues that can potentially cause serious adverse health outcomes or death.
- Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.
Level of recall
The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.
- Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.
- Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.
- Wholesale level: Affected product or batch(es) recalled from wholesale suppliers.
HSA: Health Sciences Authority
Link to the HSA announcement: https://www.hsa.gov.sg/announcements/product-recall/recall-of-twynsta-(telmisartan-amlodipine)-40mg-10mg-tablets
Only Authentic Products and Genuine Medical Supplies, at POM Marketplace!
Login or Register now to access our comprehensive range of medical supplies.
Disclaimer: The information provided on this page is intended solely for healthcare professionals for informational purposes only. While we strive for accuracy, POMConnect assumes no liability for errors or omissions. The content here should not be considered a substitute for professional medical advice. POMConnect does not endorse specific treatments or external websites linked from this page. Please note that the information is accurate at the time of publication and does not account for any modifications or updates made to the original research article after its initial publish date. POM Marketplace is accessible to qualified healthcare professionals only. Any unauthorized access or use by individuals who do not meet this criteria is prohibited.
